Amy Baxter
Staff ReporterAmy Baxter is a staff reporter for PharmaVoice. Before joining the team, she served as an editor and reporter in the B2B healthcare space for eight years at Health Exec and Home Health Care News. She also covered the retail industry as editor of Retail Leader, and hosted an Hermes award-winning weekly podcast and video interview series, Trend Talk, featuring industry executives and experts. A lifelong sailor, Amy has taken her media skills on the water to cover regattas and sailing events across the country. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Race to Mackinac Island. She is based in Florida.
123 articles by Amy Baxter
-
FDA’s new mission to speed drug reviews
June 30, 2025 -
After myriad failures, a new wave of ALS drugs approaches
June 25, 2025 -
Megablockbusters are the holy grail. Here’s how drugmakers are getting there.
June 23, 2025 -
Is DTC pharma advertising coming to an end?
June 18, 2025 -
Locked in a federal stalemate, states take PBM reform into their own hands
June 16, 2025 -
Pharma’s wins and losses in the budget bill
June 11, 2025 -
The biggest obesity deals of 2025 so far
June 9, 2025 -
FDA’s Elsa AI is here, and the industry has questions
June 5, 2025 -
The MAHA agenda won’t include expanding GLP-1 coverage — for now
June 2, 2025 -
What’s next for Trump’s ‘most favored nation’ policy?
May 27, 2025 -
Lilly’s former small molecule head makes the leap to a rising biotech in obesity
May 21, 2025 -
With the third round of Medicare price negotiations on the way, here’s how the policy is shifting
May 19, 2025 -
Trump’s ‘most favored nation’ policy is back. Here’s why it failed the first time.
May 14, 2025 -
RFK Jr.’s autism fixation hearkens back to his stance on vaccines
May 9, 2025 -
With TV ads under threat, here’s how pharma can leverage social media
May 7, 2025 -
With compounders out of the way, Lilly and Novo go after each other
May 5, 2025 -
Is the FDA headed for a major reorganization?
April 30, 2025 -
FDA’s job cuts paint mixed picture for drugmakers’ R&D plans
April 28, 2025 -
Trump reveals pharma reform priorities in drug pricing executive order
April 23, 2025 -
Can anything threaten Novo and Lilly’s obesity market dominance?
April 21, 2025 -
Novartis scores NFL deal to tackle health outcomes
April 17, 2025 -
‘Chaos’ in the biotech market has dampened hopes of a rebound. What does that mean for dealmaking and IPOs?
April 15, 2025 -
US vs. EU: When it comes to novel Alzheimer’s drugs, regulators can’t seem to agree
April 7, 2025 -
Is the FDA ‘finished’? Leadership drain hits agency hard.
April 2, 2025 -
In the obesity triple-agonist blockbuster race, a familiar battle looms: Novo vs. Lilly
March 31, 2025